EU Approval for Australian Maker of Medicinal Pet Pot
Medicinal cannabis company Creso Pharma, which aims to launch two medicinal cannabis pet products by April, has been registered by the EU health authority.
An Australian pharmaceutical developer has received the European Union's first ever health registration to commercialise medical cannabis for pets.
ASX-listed Creso Pharma is now registered with the EU and is in the process of applying for a global import and export license as it aims to sell two cannabidiol-based pet products by April.
The products, which are essentially food additives for horses and dogs, are designed to help target behavioural disorders including anxiety and noise phobias as well as chronic pain, arthritis and diabetes.
Shares in Creso Pharma, which has been developing cannabis- and hemp-derived supplements for both humans and animals, gained 2.5 cents, or 11.9 per cent, to 23.5 cents.
Chief executive and co-founder Miri Halperin Wernli said the registration marked a huge milestone for...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin